Sort
172,184 grants matching “inflammation”
Arterial Dysfunction: Basic and Clinical Mechanisms
$2,083,243Brigham And Women'S Hospital · P01 · FY2005 · HL
Center of Research in Obesity and Cardiovascular Disease (1P20 RR021954-01A1)
$2,082,003Lisa A Cassis · University Of Kentucky · P20 · FY2008 · RR
CENTER OF RESEARCH IN OBESITY AND CARDIOVASCULAR DISEASE (1P20 RR021954-01A1)
$2,082,003Lisa A Cassis · University Of Kentucky · P20 · FY2008 · RR
Genetic and Biochemical Approaches to Tyrosine Kinase Function
$2,080,841Pamela Schwartzberg · National Human Genome Research Institute · ZIA · FY2009 · HG
Genetics, Epigenetics, and Post-translational Modifications and the Development of Ventilator Induced Lung Injury (VILI)
$2,080,830Stephen M Black · Florida International University · P01 · FY2021 · HL
Mechanism of oxidative/nitrosative stress and inflammation-induced tissue injury
$2,080,616Pal Pacher · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2019 · AA
Role of Eosinophils in Airway Inflammation and Remodeling
$2,080,220Nizar N Jarjour · University Of Wisconsin-Madison · P01 · FY2011 · HL
Role of Eosinophils in Airway Inflammation and Remodeling
$2,080,220Nizar N Jarjour · University Of Wisconsin-Madison · P01 · FY2010 · HL
Role of Eosinophils in Airway Inflammation and Remodeling
$2,080,220Nizar N Jarjour · University Of Wisconsin-Madison · P01 · FY2012 · HL
Role of Eosinophils in Airway Inflammation and Remodeling
$2,080,220Nizar N Jarjour · University Of Wisconsin-Madison · P01 · FY2009 · HL
In vivo proton MRS studies:cerebral injury in HIV infection
$2,080,218Bradford A Navia · Tufts University Boston · R01 · FY2009 · NS
Mentoring Translational Researchers in Louisiana
$2,079,946Augusto C Ochoa · Lsu Health Sciences Center · P20 · FY2006 · RR
SCOR--CELLULAR AND MOLECULAR MECHANISMS OF ASTHMA
$2,079,915University Of Wisconsin Madison · P50 · FY2004 · HL
Development of MMP-9 inhibitory monoclonal antibodies to relieve neuropathic pain
$2,079,796Xin Ge · University Of Texas Hlth Sci Ctr Houston · UG3 · FY2025 · NS
A Comparative Effectiveness & Long-term Health Study in Wisconsin Smokers
$2,079,714Michael C Fiore · University Of Wisconsin-Madison · R01 · FY2014 · HL
Center of Research in Obesity and Cardiovascular Disease (1P20 RR021954-01A1)
$2,079,402Lisa A Cassis · University Of Kentucky · P20 · FY2012 · GM
A Cardiovascular-NASH disease nexus: Common Mechanisms and Treatments?
$2,078,938Christopher K Glass · University Of California, San Diego · P01 · FY2024 · HL
Glycan Modulation of Inflammatory Responses
$2,078,467Ajit P Varki · University Of California, San Diego · P01 · FY2011 · HL
BEACH: Biomarker and Edema Attenuation in IntraCerebral Hemorrhage Phase 2a Trial
$2,078,174Daniel F Hanley · Johns Hopkins University · R01 · FY2021 · AG
PREVENTABLE Data Coordinating Center
$2,077,632Bradley G Hammill · Duke University · U19 · FY2023 · AG
Mechanisms of Immune Activation and Disease Progression in Animal Models
$2,077,444Jason Brenchley · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Neuroscience, Immunology, Social Adversity and the Roots of Addictive Behaviors: Toward a New Framework for Drug Use Etiology and Prevention
$2,077,136Steven R Beach · University Of Georgia · P50 · FY2022 · DA
Iowa Phase II Clinical Trials of Novel Therapies for Lung Diseases (U01
$2,076,535Lakshmi Durairaj · University Of Iowa · U01 · FY2011 · HL
Ancillary Study 1
$2,076,535Joseph Zabner · University Of Iowa · U01 · FY2011 · HL
Vascular Inflammation and Atherosclerosis
$2,076,482Bradford C Berk · University Of Rochester · P01 · FY2009 · HL